Philippines approves emergency use of J&J, Bharat BiotechCOVID-19 vaccines

1 minute read
Register now for FREE unlimited access to Reuters.com

MANILA, April 20 (Reuters) - The Philippines' Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson & Johnson (JNJ.N) and India's Bharat Biotech, it said on Tuesday.

Both vaccines can be administered to people aged 18 and above in the Philippines, the agency chief, Rolando Enrique Domingo, said in a mobile text message.

The single-shot coronavirus vaccines developed by J&J's unit Janssen and Bharat Biotech's Covaxin are the fifth and sixth to receive emergency use approval in the Philippines, which is battling one of the worst outbreaks in Asia.

J&J is conducting late-stage clinical trials for its COVID-19 vaccine in the Philippines.

Register now for FREE unlimited access to Reuters.com
Reporting by Neil Jerome Morales; Editing by Tom Hogue

Our Standards: The Thomson Reuters Trust Principles.